Selegiline in Treatment of Cocaine Dependence - 2

• Status: Completed
• Trial end date: 1995-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Pennsylvania
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Cocaine; Selegiline

Criteria

Please contact site for information.